Skip to main content
TOWA PHARMACEUTICAL CO.,LTD. logo

TOWA PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4553 ISIN · JP3623150004 LEI · 35380036BH1C3PNO2426 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country JP Japan
Listing T 4553

About TOWA PHARMACEUTICAL CO.,LTD.

https://www.towayakuhin.co.jp/english/

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and high added-value therapeutic solutions. Its product portfolio primarily consists of generic medications, which are distributed as ethical drugs, and also includes other products such as vitamins and antibiotics. The company focuses on the entire lifecycle of its pharmaceutical products, from initial development to final distribution, to meet various healthcare needs.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 86% confidence The document is clearly a Japanese ‘臨時報告書’ (Extraordinary / Timely Disclosure Report) filed under the Financial Instruments and Exchange Act with the Kinki Finance Bureau. It details a material financial event (impairment loss and special loss) rather than being an AGM packet, earnings summary, interim or annual report, or any other specified filing type. It is not an announcement of publication but the report itself. There is no dedicated category for a Japanese timely disclosure (akin to an 8-K), so it falls under the general “Regulatory Filings” category as a fallback.
2026-05-27 Japanese
臨時報告書
Share Issue/Capital Change Classification · 92% confidence The document is a Japanese "臨時報告書" relating to a third-party allotment of Type A preferred shares by TOWA Pharmaceutical Co., Ltd. It details the number of shares, issue price, capital increase, use of proceeds and allottee information — all elements of a new share issue/capital change announcement. Therefore it falls under Share Issue/Capital Change (SHA).
2026-05-25 Japanese
役員人事に関するお知らせ
Board/Management Information Classification · 95% confidence The document is a corporate announcement titled “役員人事に関するお知らせ” (“Notice regarding officer personnel changes”), detailing nominations and reappointments of directors and audit committee members, board makeup and future AGM resolutions. This clearly matches an announcement of changes in the company’s board of directors or senior management (MANG).
2026-05-21 Japanese
第三者割当によるA種優先株式の発行、定款の一部変更ならびに 資本金および資本準備金の額の減少に関するお知らせ
Share Issue/Capital Change Classification · 95% confidence The document is a corporate announcement detailing a third-party allotment of Class A preferred shares, amendments to the articles of incorporation, and a decrease in capital and capital reserves. It is not an annual or quarterly report, earnings release, or management discussion, but specifically relates to issuance of new shares and related capital changes. Under the filing definitions, this corresponds to Share Issue/Capital Change (SHA).
2026-05-21 Japanese
減損損失の計上、当社個別決算における関係会社株式評価損の計上ならびに業績予想の修正に関するお知らせ
Regulatory Filings Classification · 85% confidence The document is a Tokyo Stock Exchange “TDnet” style notice (“お知らせ”) reporting an impairment loss, valuation loss on affiliate shares, and a revision to the full-year earnings forecast for the fiscal year ending March 2026. It does not contain actual audited financial statements (so it’s not an Annual or Interim Report), nor is it the initial earnings release. It is a standalone regulatory announcement of forecast revisions and accounting actions, fitting the general “Regulatory Filings” category (RNS).
2026-05-11 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の5の2第1項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a semi-annual report. H1 70
2025-11-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.